2018
DOI: 10.1016/j.otsr.2018.08.008
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of the clinical effectiveness of Bone Morphogenic Protein (BMP) -2 and -7 in the adjunct treatment of lower limb nonunions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
34
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 52 publications
(34 citation statements)
references
References 25 publications
0
34
0
Order By: Relevance
“…Overall, we found ten studies which met our inclusion criteria, including five retrospective cohort or case–control studies [4, 6, 9, 12, 13], three prospective cohort studies [10, 11, 55] and two case reports [7, 8]. One study was excluded (case report by Dilogo et al.…”
Section: Resultsmentioning
confidence: 99%
“…Overall, we found ten studies which met our inclusion criteria, including five retrospective cohort or case–control studies [4, 6, 9, 12, 13], three prospective cohort studies [10, 11, 55] and two case reports [7, 8]. One study was excluded (case report by Dilogo et al.…”
Section: Resultsmentioning
confidence: 99%
“…One-step treatment consists of debridement of the non-union and surrounding avital tissue, de-novo osteosynthesis with a suitable and biomechanically stable implant, filling of the osseous defect with autologous bone graft and occasional application of additional growth factors such as bone morphogenic protein 2 or 7 (3.3 mg BMP-7 or 4 mg BMP-2). 18,19 Typically, Masquelet therapy consists of two surgical procedures or steps; however, if an infection is detected the first step is repeated until asepsis is achieved. In detail, the individual steps involve the following aspects:…”
Section: Surgical Treatmentmentioning
confidence: 99%
“…Toosi et al precisely described in a review a range of growth factors and cytokines provided by bone resident MSCs to support cell growth following injury and demonstrated how GF signaling plays a critical role in regulating osteogenesis, chondrogenesis and bone/mineral homeostasis [57]. It is known that the delivery of exogenous GFs, i.e., BMP-2, to the non-union bone fracture site remarkably improves healing results [58].…”
Section: Conditioning Systems Composites and Growth Factorsmentioning
confidence: 99%